



Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
GI24 Double Nickase Plasmid (h) | sc-407831-NIC | 20 µg | $410.00 | |||
GI24 Double Nickase Plasmid (h2) | sc-407831-NIC-2 | 20 µg | $410.00 |
VSIR (V-set immunoregulatory receptor), also known as GI24/VISTA, encodes a B7 family immune checkpoint molecule that modulates T cell activation and helps maintain peripheral tolerance. GI24 is expressed primarily in hematopoietic and myeloid compartments, where it influences antigen-presenting cell function and dampens inflammatory cytokine programs. Through regulation of co-stimulatory signaling, VSIR contributes to immune homeostasis at tissue sites and within the tumor microenvironment. Dysregulated VSIR expression or signaling has been associated with altered anti-tumor immunity and chronic inflammatory states, making it a useful target for mechanistic studies of immunoregulation.
GI24 Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the VSIR locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within VSIR. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt VSIR function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.
To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of VSIR-disrupted clones.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.